Skip to Main Content

Paper Details

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Bone Marrow Transplant
9
2022
Author NameAffiliation
Zhaolei ZhangUniversity of Toronto
Zhaolei ZhangUniversity of Toronto
Zhaolei ZhangUniversity of Toronto
  • 1 - 3

Datasets